Tonous N. Silfani

Use of 24-h ambulatory blood pressure monitoring to assess blood pressure control: a comparison of olmesartan medoxomil and amlodipine besylate

T. Marbury, S. Chrysant, Tonous N. Silfani, 2006, Blood pressure monitoring.

Efficacy and Safety of Treating Stage 2 Systolic Hypertension With Olmesartan and Olmesartan/HCTZ: Results of an Open‐Label Titration Study

J. Izzo, J. Neutel, Tonous N. Silfani, 2007, Journal of clinical hypertension.

A Review of the Structural and Functional Features of Olmesartan Medoxomil, An Angiotensin Receptor Blocker

M. Pugsley, Tonous N. Silfani, D. Mire, 2005, Journal of cardiovascular pharmacology.

Phosphatidylinositide 3-kinase regulates angiotensin II-induced cytosolic phospholipase A2 activity and growth in vascular smooth muscle cells.

Tonous N. Silfani, E. J. Freeman, 2002, Archives of biochemistry and biophysics.

Comparison of Increasing Doses of Olmesartan Medoxomil, Losartan Potassium, and Valsartan in Patients With Essential Hypertension

S. Oparil, T. Giles, Tonous N. Silfani, 2007, Journal of clinical hypertension.

Role of angiotensin receptor blockers as monotherapy in reaching blood pressure goals.

S. Oparil, Tonous N. Silfani, J. Walker, 2005, American journal of hypertension.

Vascular smooth muscle and exercise

S. DiCarlo, Chao‐Yin Chen, Tonous N. Silfani, 1998 .